PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsGastroenteritis
MeSH D005759 - gastroenteritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D005767:Gastrointestinal diseases
32 Companies
12 Drugs
$
Success rate
D005759: 
Gastroenteritis
55 Companies
7 Drugs
$
Success rate
D000076385:Diverticular diseases
0 Companies
0 Drugs
Success rate
D001064:Appendicitis
12 Companies
2 Drugs
$
Success rate
D003092:Colitis
0 Companies
0 Drugs
Success rate
D004403:Dysentery
40 Companies
5 Drugs
$
Success rate
D004751:Enteritis
18 Companies
4 Drugs
$
Success rate
D004760:Enterocolitis
0 Companies
0 Drugs
Success rate
D004941:Esophagitis
85 Companies
11 Drugs
$
Success rate
D005756:Gastritis
12 Companies
3 Drugs
$
Success rate
D011349:Proctitis
22 Companies
1 Drug
$
Success rate
D015212:Inflammatory bowel diseases
49 Companies
8 Drugs
$
Success rate
D017688:Cholera morbus
0 Companies
0 Drugs
Success rate
D052016:Mucositis
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaErythromycin C-solve  1993-07-30   
Erythromycin Erythromycin  2021-02-11   
Erythromycin lactobionate Erythromycin Lactobionate  1993-07-30   
PadagisErythromycin Erythromycin  1983-09-26   
Taro PharmaceuticalErythromycin A/t/s  1982-11-18   
MylanErythromycin E-glades  2002-03-18   
Erythromycin Erygel  1987-10-21   
Erythromycin Erythromycin  1996-07-03   
Johnson & JohnsonErythromycin Erycette  1985-02-15   
WyethErythromycin lactobionate Wyamycin  1982-01-01   
AlpharmaErythromycin Erythromycin  1982-04-19   
Erythromycin lactobionate Erythromycin Ethylsuccinate  1982-01-01   
Bausch Health CompaniesErythromycin Akne-mycin  1985-01-10   
Erythromycin, Benzoyl peroxide Benzamycin  1984-10-26   
Erythromycin Erythromycin  1994-01-27   
PfizerErythromycin Eryc  1985-07-25   
Erythromycin lactobionate Erythromycin Ethylsuccinate  1982-01-01   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
57%
4/7
Phase 2
56%
5/9
Phase 3
31%
5/16
Approved: 3Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Erythromycin,
Erythromycin lactobionate
Mylan
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate
Johnson & Johnson
Erythromycin lactobionate,
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin stearate,
Domperidone
GSK
Antithrombin iii,
Ipv,
Pcv
Bausch Health Companies
Benzoyl peroxide,
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate
Pfizer
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate
Eli Lilly
Erythromycin,
Erythromycin lactobionate
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use